Denali Therapeutics Inc. - COM (DNLI)

Q4 2019 13F Holders as of 12/31/2019

Type / Class
Equity / COM
Number of holders
107
Total Shares
70.7M
Shares change
-601K
Total reported value, excl. options
$1.23B
Value change
-$9.53M
Put/Call ratio
1.27
Number of buys
40
Number of sells
-51
Price
$17.42
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.